Assesses clinical and biological features predicting quality of life outcomes in CASPR2-antibody encephalitis, indicating important prognostic factors.
To assess the clinical and biological features that predict quality of life outcomes after immunotherapy in CASPR2-antibody disease.
No takes yet. Share an insight, caveat, or question.
Ceronie et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: